CDIVX Mutual Fund

NAV$13.03

Fund Essentials - as of May 31, 2026

Net Assets
$9M
Expense Ratio
1.05%
Dividend Yield (Current)
9.00%
Holdings
68
Inception Date
Mar 1, 2013
Fund Family
Copeland Capital Management LLC
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+5.06%
1 Year+11.59%
3 Year+9.31%
5 Year+6.64%
10 Year+8.16%

Asset Allocation

Stocks: 99.92%
Cash: 0.07%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LRCXLam Research Corpcommon Stock2.67%
AVGOBroadcom Inc2.64%
AAPLApple Inc2.63%
MSMorgan Stanley2.45%
WCCWesco International Inc2.36%
Top 10 Concentration: 24.13%Report Date: May 31, 2026
Download all 68 holdings for CDIVX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
9.00%
Frequency
Annually
Latest Distribution
$1.69
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how CDIVX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$99/yr
7-day refund. Cancel anytime.
X-ray my whole portfolio
$99/yr Pro · 7-day refund. From MarketXLS, trusted since 2014.

CDIVX Mutual Fund Overview

CDIVX Mutual Fund (Copeland Dividend Growth Fund Class I) is managed by Copeland Capital Management LLC with $9.5M in net assets. CDIVX expense ratio is 1.05%, holding 68 positions across sectors including Information Technology, Industrials, Financials. Inception date: 2013-03-01.

CDIVX performance shows a YTD return of 5.06%. The 1-year return is 11.59% and the 5-year return is 6.64%. CDIVX dividend yield stands at 9.00%, paid annually.

CDIVX top holdings include Lam Research Corpcommon Stock (2.7%), Broadcom Inc (2.6%), Apple Inc (2.6%), Morgan Stanley (2.5%), Wesco International Inc (2.4%). View all CDIVX holdings, sector breakdown, or dividend history.

CDIVX can be compared against other funds using the overlap calculator or side-by-side comparison tool. CDIVX alternatives are available via the screener, along with tax-loss harvesting opportunities.